Skip to main content

This website is intended for ROI Irish healthcare professionals only

Bayer Ireland
SmPC

To visit the global (BRAND) website, please choose from the options below:

Yes

The information on this site is intended for
healthcare professionals based in the Republic of Ireland only.

Are you a healthcare professional based in the Republic of Ireland?

Yes

Prostate Cancer
NTRK Gene Fusion Cancer
Tyrosine Kinase Inhibitors

Toggle Search

Prostate Cancer
NTRK Gene Fusion Cancer
Tyrosine Kinase Inhibitors

Bayer Ireland
SmPC

Country select
- Country 1
- Country 2

Bayer UK
Prescribing Information
SmPC

Breadcrumb

Home

403 access denied page

The Page cannot be accessed. Please log in to access the page.

PP-PF-ONC-IE-0024-6, November 2024

Privacy Statement
Conditions of use
Imprint
Contact us
Prescribing Information:
VITRAKVI (larotrectinib)
Xofigo (radium-223 dichloride)
NUBEQA (darolutamide)
Nexavar (sorafenib)
Stivarga (regorafenib)

© Bayer Limited. All rights reserved

This website is intended for Irish healthcare professionals only. www.oncology.bayer.ie is organised and funded by Bayer and contains promotional content.

PP-PF-ONC-IE-0064-1, February 2025

Abbreviated Prescribing Information (PI) can be found via the links below:

VITRAKVI (larotrectinib) Xofigo (radium-223 dichloride) NUBEQA (darolutamide) Nexavar Stivarga

^▼This medical product is subject to additional monitoring. This will allow quick identification of new safety informaton.

hidden link for autofocus

image of a half-eaten cookie